1The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke[J].N Engl J Med,1995,333:1581-1587.
2Grotta JC,Welch KM,Fagan SC,et al.Clinical deterioration following improvement in the NINDS rtPA Stroke Trial[J].Stroke,2001,32:661-668.
3Demchuk AM,Burgin WS,Christou I,et al.Thrombolysis in brain ischemia(TIBI) transcranial Doppler flow grades predict clinical severity,early recovery,and mortality in patients treated with intravenous tissue plasminogen activator[J].Stroke,2001,32(1):89-93.
4Alexandrov AV,Demchuk AM,Felberg RA,et al.High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz trancranial Doppler monitoring[J].Stroke,2000,31:610-614.
5Molina CA,Montaner J,Arenillas JF,et al.Differential pattern of tPA-induced proximal MCA recanalization among stroke subtypes[J].Stroke,2004,35:486-490.
6Blinc A,Francis CW.Transport processes in fibrinolysis and fibrinolytic therapy[J].Thromb Haemost,1996,76:481-491.
7Higashida RT,Furlan AJ.Trial design and reporting standards for intra-arterial thrombolysis for acute ischemic stroke[J].Stroke,2003,34:e109-e137.
